What is Alibaba Health Information Technology Operating Cash Flow per Share?
Alibaba Health Information Technology's operating cash flow per share for the
six
months ended in Mar. 2025 was HK$0.06.
Alibaba Health Information Technology's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was HK$0.09.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Alibaba Health Information Technology was 12.00% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 33.60% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Alibaba Health Information Technology's Operating Cash Flow per Share or its related term are showing as below:
HKSE:00241'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -78.3 Med: -2.7 Max: 33.6
Current: 33.6
During the past 13 years, Alibaba Health Information Technology's highest 3-Year average Operating Cash Flow per Share Growth Rate was 33.60% per year. The lowest was -78.30% per year. And the median was -2.70% per year.
HKSE:00241's 3-Year OCF Growth Rate is ranked better than 81.68% of 524
companies
in the Healthcare Providers & Services industry
Industry Median: 7.8
vs HKSE:00241: 33.60
Alibaba Health Information Technology Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Alibaba Health Information Technology Operating Cash Flow per Share Chart
Competitive Comparison of Alibaba Health Information Technology's Operating Cash Flow per Share
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.09
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Alibaba Health Information Technology's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00241 has been successfully added to your 